View Clinical Trial (Medical Research Study)

PACE-CALL: A Weight Control Intervention for Survivors of Childhood Leukemia - NCT01171599-92037(Clinical Trial 712851)



ClinicalConnection.com has recently undergone an update and this page may no longer be up-to-date. Please Search For Clinical Trials to view the most current clinical trials listings.


Signup
City:  La Jolla
State:  
CA
Zip Code: 92037
Conditions: Obesity - Overweight - Weight Loss - Weight Maintenance
Purpose: The purpose of this National Cancer Institute (NCI) funded study is to develop and test the acceptability and usability of a web & text message based weight loss intervention for childhood acute lymphoblastic leukemia (ALL) survivors. Childhood cancer survivors ages 7 - 18 will provide feedback during focus groups on a web and text message based program that was developed.
Study summary: This is a two year study to develop a predominantly web-based behavioral assessment and intervention program (PACE-CALL) that will provide individual assessment and tailoring of a behavioral intervention for adolescent children Acute Lymphoblastic Leukemia (ALL) survivors and their families. In addition, we are conducting formative research to adapt the abovementioned program to children and adolescents aged 7 - 18 who survived any cancer. Focus Groups: Web-Based & Text Message Intervention Feedback Two focus groups will be conducted with adolescent cancer survivors and their families, to assess the usability and acceptability of the web-based intervention, focus groups will be conducted. The two focus groups will last 2 hours with 6-8 people in each group: one focus group with youth & adolescents (age 7 - 18 who are representative of the target population to determine the appropriateness of the web-based intervention one focus group with the parents of the children in the focus group mentioned above (it will occur at the same time). All focus groups will begin with an overview of the study and description of the web-based intervention components. Focus group participants will see sample web pages and may be asked to provide feedback on some or all of the following: Youth, Adolescent or Parent: - How does the web-based and text message based intervention address issues faced by children who have survived cancer? - What do you like about the web-based intervention? What do you not like about the web-based intervention? What would you change about the web-based intervention? - What do you like about the text messages? What do you not like about the text messages? - Would you want to join a program like this? Why or why not? - If you were to be in this program, how often would you log on to the web-based intervention? How often would you want to receive text messages? - What are some of the barriers to joining a program like this?
Criteria: Inclusion Criteria: - Are 7 - 18 years - Provide assent and have a legal guardian that will participate and provide parental permission/consent - Are a cancer survivor (off treatment for two years) - Are overweight or obese (85th percentile BMI (Body Mass Index) for age and gender) Exclusion Criteria: o Have any of the following comorbidities of obesity that require immediate sub-specialist referral including pseudotumor cerebri, sleep apnea, and obesity hypoventilation syndrome
Study is available at: UCSD, Atkinson Hall, 3rd Floor
La Jolla, CA 92037
United States

Primary Contact:
Jill Rybar, MPH
Email: jrybar@ucsd.edu
Phone: 858-534-9313

Secondary Contact:
Lindsay Dillon, MPH
Email: ldillon@ucsd.edu
Phone: 858.534.9329
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
Trials Alerts: If you would like to be notified of new clinical trials as they become available please register for a free account.
Data Source: ClinicalTrials.gov
Date Processed: March 23, 2011
Modifications to
this listing:		 Only selected fields are shown, please use the link above to view all information about this clinical trial.